InvestorsHub Logo
Followers 101
Posts 13186
Boards Moderated 0
Alias Born 06/01/2013

Re: bow-tie post# 21288

Friday, 11/20/2020 10:24:21 AM

Friday, November 20, 2020 10:24:21 AM

Post# of 27659
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32137-1/fulltext#%20

Check out the completion dates of J&J vs Pfizer; BioNTech, Moderna & Merck

The role of mucosal immunity should not be discounted, and several intranasal vaccine formulations are under investigation.

56,

Hassan AO
Kafai NM
Dmitriev IP
et al.
A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2.
Cell. 2020; (published online Aug 19.)
https://doi.org/10.1016/j.cell.2020.08.026

57,

Bloomberg News
China starts testing COVID-19 nasal spray vaccine.
https://www.bloomberg.com/news/articles/2020-09-11/china-starts-testing-covid-19-nasal-spray-vaccine-in-world-first
Date: Sept 11, 2020
Date accessed: September 18, 2020

58

MediciNova
MediciNova announces that its intranasal COVID-19 vaccine successfully induced systemic IgG and mucosal IgA neutralizing antibodies against SARS-CoV-2 in mice using BC-PIV vector technology.
https://finance.yahoo.com/news/medicinova-announces-intranasal-covid-19-103000673.html

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYMX News